Search

everythinglearnresearchcommunity

for

Search:↓

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

Hair loss in Rhesus macaques may be caused by a skin allergy-related condition.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Scientists created a 3D skin model to study a chronic skin disease and test treatments.

Oral finasteride and dutasteride may negatively affect erectile function in rats.

Erdr1 could be a new marker for diagnosing hair loss.

Fzd2 is important for skin and hair development through various signaling ways.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Kolaviron and quercetin may help treat prostate issues.

PCOS has many symptoms, with high androgen levels being the most common.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

Transplant patients often get skin problems, with treatments varying by condition.

m-Aminophenol in hair dye can cause skin cell toxicity and stress responses.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

COVID-19 can cause over 50 long-term symptoms, with fatigue and headache being the most common.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

Early balding in young Indian men may indicate a higher risk of metabolic syndrome and potential heart disease.

Quercetin may help improve symptoms of polycystic ovary syndrome.

Toxic metals can cause hair loss and should be considered by doctors.

Dutasteride and finasteride cause kidney damage, with dutasteride being more harmful.

Alopecia areata may be linked to heart issues.

High YKL-40 levels predict early hair loss and hidden metabolic issues.